WMSA
DMRA

Weiss Multi-Strategy Advisers’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-646
Closed -$98K – 723
2021
Q1 		$98K Sell
646
-1,000
-61% -$272K ﹤0.01% 682
2020
Q4 		$515K Buy
+1,646
New +$612K 0.01% 561

Other funds holding DMRA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's DMRA Position: Q2 2021 in Review

Weiss Multi-Strategy Advisers sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2021, closing a stake of 646 shares — an estimated $98K sold.

Weiss Multi-Strategy Advisers first reported a position in DMRA in Q4 2020 and held it in 2 quarters. The position peaked at $515K in Q4 2020. 26 funds tracked by Wall St. Rank hold DMRA as of Q2 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 646 Damora Therapeutics, Inc. Ordinary Shares shares in Q2 2021, an estimated $98K.
  • Weiss Multi-Strategy Advisers first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Damora Therapeutics, Inc. Ordinary Shares position peaked at $515K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.